Pfizer (PFE) Current Taxes (2016 - 2025)
Historic Current Taxes for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $3.8 billion.
- Pfizer's Current Taxes rose 3204.73% to $3.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year increase of 3204.73%. This contributed to the annual value of $2.9 billion for FY2024, which is 2388.25% up from last year.
- Per Pfizer's latest filing, its Current Taxes stood at $3.8 billion for Q3 2025, which was up 3204.73% from $3.7 billion recorded in Q2 2025.
- Pfizer's Current Taxes' 5-year high stood at $4.5 billion during Q4 2021, with a 5-year trough of $1.3 billion in Q4 2021.
- Its 5-year average for Current Taxes is $2.7 billion, with a median of $2.9 billion in 2024.
- In the last 5 years, Pfizer's Current Taxes surged by 21440.56% in 2021 and then tumbled by 3819.6% in 2023.
- Quarter analysis of 5 years shows Pfizer's Current Taxes stood at $1.3 billion in 2021, then increased by 25.36% to $1.6 billion in 2022, then skyrocketed by 48.02% to $2.3 billion in 2023, then grew by 23.88% to $2.9 billion in 2024, then soared by 30.55% to $3.8 billion in 2025.
- Its Current Taxes stands at $3.8 billion for Q3 2025, versus $3.7 billion for Q2 2025 and $3.1 billion for Q1 2025.